-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ikena Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Ikena Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.4M, a 36.4% increase year-over-year.
- Ikena Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$68.4M, a 0.38% increase year-over-year.
- Ikena Oncology, Inc. annual Operating Income (Loss) for 2023 was -$75.4M, a 6.37% decline from 2022.
- Ikena Oncology, Inc. annual Operating Income (Loss) for 2022 was -$70.9M, a 108% decline from 2021.
- Ikena Oncology, Inc. annual Operating Income (Loss) for 2021 was -$34.1M, a 23.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)